Method Article

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni

DOI:

10.3791/56345

January 14th, 2018

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This article describes a protocol for the large-scale axenic isolation and collection of free-swimming miracidia of the human blood fluke Schistosoma mansoni and their subsequent processing for introduction into in vitro culture.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Human blood flukes, Schistosoma spp., have a complex life cycle that involves asexual and sexual developmental phases within a snail intermediate and mammalian final host, respectively. The ability to isolate and sustain the different life cycle stages under in vitro culture conditions has greatly facilitated investigations of the cellular, biochemical and molecular mechanisms regulating parasite growth, development and host interactions. Transmission of schistosomiasis requires asexual reproduction and development of multiple larval stages within the snail host; from the infective miracidium, through primary and secondary sporocysts, to the final cercarial stage that is infective to humans. In this paper we present a step-by-step protocol for mass hatching and isolation of Schistosoma mansoni miracidia from eggs obtained from livers of infected mice, and their subsequent introduction into in vitro culture. It is anticipated that the detailed protocol will encourage new researchers to engage in and broaden this important field of schistosome research.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The human blood flukes Schistosoma spp., are the causative agents of schistosomiasis, a neglected tropical disease afflicting an estimated 230 million people worldwide1. The most widespread species, Schistosoma mansoni, is geographically distributed in South America, the Caribbean archipelago, the Middle East and sub-Saharan Africa2. The life cycle of S. mansoni, and other schistosomes, is complex, involving a mammalian definitive host and freshwater snails of the genus Biomphalaria that serve as obligate intermediate hosts.

S. mansoni male and fema....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee of the University of Wisconsin-Madison under Protocol no. V005717. The following protocol involves working in a Biosafety Level 2 (BSL2) facility for human pathogens, although none of the schistosome stages depicted in this protocol are infective to humans or other mammals. Follow institutional policies for handling Risk Group 2 (RG2) human pathogens.

NOTE: We use female Swiss-Webster mice (6-week old) due to their higher susceptibility to infection10, thereby yielding larger egg burdens. Tucker et al.

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The vast majority of miracidia typically will have been collected in the first two "harvests". Incubation of isolated miracidia in CBSS+ triggers the miracidium-to-sporocyst transformation process (Figure 4A-C). Within the first hour following transfer to culture wells containing CBSS+, the majority of miracidia cease swimming (Figure 4A). At 6 h in culture, miracidia are in the process of actively shedding their.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Miracidia of S. mansoni, isolated and manipulated as described herein, can infect only the snail intermediate host, and therefore do not represent a human biohazard during this phase of larval development. However, to avoid accidental exposure/infection of snails, care should be taken to perform miracidial isolations in a different location from areas where susceptible Biomphalaria snail species may be present or maintained. A separate room, registered as BSL2 space, is highly recommended. In addition, .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Funded in part by NIH grant RO1AI015503. Schistosome-infected mice were provided by the NIAID Schistosomiasis Resource Center at the Biomedical Research Institute (Rockville, MD) through NIH-NIAID Contract HHSN272201000005I for distribution through BEI Resources.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Chernin's balanced salt solution (CBSS+)For 1L of solution
2.8 g sodium chlorideFisher ScientificS271-3Dissolve salts, except calcium chloride, and 
0.15 g of potassium chloride Sigma-AldrichP5405sugars in 800 mL ddH2O
0.07 g sodium phosphate, dibasic anhydrousFisher ScientificS374-500Dissolve calcium chloride separately in 200 
0.45 g magnesium sulfate heptahydrate Sigma-AldrichM1880mL ddH2O
0.53 g calcium chloride dihydrate Mallinckrodt4160Slowly add calcium soln to the salt/sugar soln with 
0.05 g sodium bicarbonate  Fisher ScientificS233-3with constant mixing
1 g glucoseMP Biomedicals152527Adjust to pH 7.2 and filter sterilize using a 
1 g trehaloseSigma-AldrichT01670.22 µm disposable bottle-top filter
10 mL 100X penicillin/streptomycinHycloneSV30010Add filtered penicillin and streptomycin soln 
prior use
Incomplete Bge  medium (Ibge)For 900 mL solution
220 mL Schneider’s Drosophila medium modifiedLonza04-351QMix Schneider's medium with 680 mL ddH2O
4.5 g lactalbumin enzymatic hydrolysateSigma-AldrichL9010Add lactalbumin hydrolysate and galactose
1.3 g galactoseSigma-AldrichG0625Adjust to pH 7.2 and filter sterilize using a 0.22 µm
pre-sterilized disposable bottle-top filter
Complete Bge medium (cBge)For 100 mL of solution
90 mL Incomplete Bge mediumTo heat-inactivate FBS: Incubate thawed FBS in 
9 mL heat-inact. fetal bovine serum (FBS) (Optima)Atlanta BiologicalsS12450waterbath at 60°C for 1 hr while gently 
1 mL 100X penicillin/streptomycinHycloneSV30010swirling the bottle every 10 min
Aliquot heat-inactivated FBS into 15-mL tubes 
and store at -20°C.  Mix medium + FBS and
filter sterilize using a 0.22 µm pre-sterilized 
disposable bottle-top filter 
Add penicillin and streptomycin prior to use
Pond water (stock solution)1L of stock solution
12.5 g calcium carbonateFisher ScientificC64-500Mix all salts in 1L of ddH2O
1.25 g magnesium carbonateFisher ScientificM27-500Note that the salts will not have completely 
1.25 g  sodium chlorideFisher ScientificS271-3dissolved.  Shake vigorously to suspend                
0.25 g  potassium chlorideSigma-AldrichP5405salts prior to making the working soln  
Pond water (working solution)1.5L of solution
0.8 mL stock solution pond water (shake prior use) in        Mix stock to ddH2O
1500 mL of ddH2OSterilize pond water by autoclaving (slow cycle)
1.5 mL of 100X penicillin/streptomycin HycloneSV30010Add penicillin and streptomycin prior use
Saline solution (1.2% NaCl)1.5L of solution
18 g sodium chloride in 1500 mL of ddH2OFisher ScientificS271-3Autoclave saline solution to sterilize
1.5 mL of 100X penicillin/ streptomycinHycloneSV30010Add penicillin and streptomycin prior use
Additional equipment and material: 
7-L mouse euthanizing chamberFollowing approved IACUC protocol no. V001551
MiceTaconic BiosciencesSwiss-Webster, female, 6-wk old, murine  
CO2 tank and regulatorpathogen-free
24-well tissue culture plateTPP92424
1-L volumetric flasks
Light source (150W)Chiu Tech CorpModel F0-150
Centrifuge, refrigerated, swinging bucketEppendorfModel 5810R
Centrifuge bottles (250 mL)Nalgene
15-mL centrifuge tubes, sterileCorning430053
Sterile disposable transfer pipets Fisher Scientific1371120
0.22 µm pre-sterilized disposable bottle-top filter EMD MilliporeSCGPS05RE
Stainless steel blenderWaring CommercialModel 51BL31
Blender cup, 100 mL capacityWaring Commercial
Inverted compound microscopeNikon Instruments Eclipse TE300

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Colley, D. G., Bustinduy, A. L., Secor, W. E., King, C. H. Human schistosomiasis. Lancet. 383, 2253-2264 (2014).
  2. WHO. Schistosomiasis: number of people treated worldwide in 2013. Wkly. Epidemiol. Rec. 5 (90), 25-32 (2015).
  3. Yoshino, T. P., Gourbal, B., Théron, A. Schistosoma sporocysts.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Schistosoma MansoniMiracidia IsolationIn Vitro CultivationLiver Tissue ProcessingEgg ExtractionCentrifugation WashingPond Water AttractionChernin Balanced SaltTissue Culture PlateParasite Life Cycle

Related Articles